UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement
Sales, net	$ 10,125	$ 9,655	$ 31,213	$ 30,446
Cost of goods sold	3,629	3,880	11,288	12,196
Gross profit	6,496	5,775	19,925	18,250
Operating expense:
Selling, general and administrative	1,714	1,701	5,146	5,320
Research & development	103	135	341	364
Total operating expense	1,817	1,836	5,487	5,684
Operating income	4,679	3,939	14,438	12,566
Other income (expense)	17	41	65	206
Income before provision for income taxes	4,696	3,980	14,503	12,772
Provision for income taxes	1,074	1,045	3,476	3,361
Net income	$ 3,622	$ 2,935	$ 11,027	$ 9,411
Earnings per common share (basic)	$ 0.97	$ 0.78	$ 2.97	$ 2.50
Earnings per common share (diluted)	$ 0.97	$ 0.78	$ 2.95	$ 2.49
Shares outstanding (basic)	3,719	3,761	3,716	3,757
Shares outstanding (diluted)	3,738	3,778	3,734	3,775
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ 1,219	$ (430)	$ 3,550	$ (3,856)
Unrealized gain (loss) on investments net of taxes of $2, $2, $5 and ($2)	4	3	9	(3)
Total comprehensive income	$ 4,845	$ 2,508	$ 14,586	$ 5,552